COVID vaccine: Russia registers nasal version of Sputnik V Ruchika Sharma3 April 2022 11:30 AM ISTThe nasal vaccine will be efficient against the new Omicron coronavirus strain, Gintsburg said.
Pfizer COVID vaccine cut Omicron hospitalisations by 68 percent in kids aged 5-11 MD Bureau3 April 2022 10:30 AM ISTNew York: Vaccination of 5 to 11-year-olds reduced hospitalisations with Covid-19 by more than two thirds during the Omicron surge and also protected...
Novavax seeks conditional marketing nod for Nuvaxovid in adolescents Ruchika Sharma3 April 2022 9:00 AM ISTGaithersburg: Novavax, Inc. has announced submission of its request to expand the conditional marketing authorization (CMA) of Nuvaxovid COVID-19...
COVID-19: Bharat Biotech temporarily slows down Covaxin production Ruchika Sharma2 April 2022 10:30 AM IST"For the coming period, the company will focus on pending facility maintenance, process, and facility optimisation activities," Bharat Biotech said in...
Pericardial Effusion in Hospitalized COVID Patients Indicates Worse Prognosis MD Bureau2 April 2022 9:00 AM ISTCOVID-19 infection has a wide range of disease severity, from asymptomatic or mild, self-limiting illness to severe progressive pneumonia, multiorgan...
BioNTech to expand clinical trial programme for more anti-Omicron vaccine options MD Bureau31 March 2022 4:53 PM ISTBioNTech said on Wednesday it would expand an ongoing clinical trial programme to develop new vaccines and patterns of administration for better...
Even mild COVID-19 infection raises blood sugar and risk of incident diabetes MD Bureau31 March 2022 10:30 AM ISTThe human pancreas is a target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Following SARS-CoV-2 infections, reduced numbers of...
UK study to test Pfizer COVID drug Paxlovid in hospitalised patients Ruchika Sharma31 March 2022 9:45 AM ISTRecovery, led by the University of Oxford, will probe whether Paxlovid shortens the length of hospital stay or reduces the need for a mechanical...
Pfizer gets expanded USFDA emergency use nod for additional COVID Vaccine booster in adults aged 50 years and older Ruchika Sharma30 March 2022 12:25 PM ISTThe additional booster is to be administered at least four months after the first booster and is the same formulation and strength as prior...
Sanofi targets eczema-treatment product Dupixent peak sales of over 13 billion euros Ruchika Sharma29 March 2022 1:21 PM ISTParis: French healthcare group Sanofi, which lagged rivals in the race for COVID-19 vaccines, raised on Tuesday its peak sales target for...
UGC warns students against Chinese universities says online degrees invalid Roshni Dhar28 March 2022 3:02 PM ISTAdvising the students to exercise "due diligence" while choosing their destination for medical education, the apex body for higher education in India...
Sapigen Biologix, Technology Development Board collaborate for malaria, COVID nasal vaccine Ruchika Sharma28 March 2022 11:00 AM ISTNew Delhi: The Technology Development Board (TDB) of the Union Ministry of Science and Technology and Sapigen Biologix Private Limited, Hyderabad on...
